Free Trial

BioLife Solutions (BLFS) News Today

BioLife Solutions logo
$26.14 -0.31 (-1.17%)
As of 01/17/2025 04:00 PM Eastern
BioLife Solutions, Inc. stock logo
Short Interest in BioLife Solutions, Inc. (NASDAQ:BLFS) Rises By 5.8%
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 3,310,000 shares, a growth of 5.8% from the December 15th total of 3,130,000 shares. Based on an average trading volume of 379,000 shares, the short-interest ratio is presently 8.7 days.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of "Buy" by Brokerages
Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned an average recommendation of "Buy" from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average
Craig-Hallum Sticks to Their Buy Rating for BioLife Solutions (BLFS)
What is Northland Capmk's Forecast for BLFS Q4 Earnings?
BioLife Solutions sees Q4 revenue $22.7M, consensus $21.55M
BioLife Solutions, Inc. stock logo
Q4 EPS Estimate for BioLife Solutions Decreased by Analyst
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at Northland Capmk lowered their Q4 2024 earnings estimates for shares of BioLife Solutions in a research report issued to clients and investors on Wednesday, January 8th. Northland Capmk analyst C. Byrnes now expects that th
Research Analysts Set Expectations for BLFS Q4 Earnings
Craig-Hallum Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
BioLife Solutions, Inc. stock logo
Northland Capmk Weighs in on BLFS Q4 Earnings
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Equities researchers at Northland Capmk issued their Q4 2025 earnings per share (EPS) estimates for BioLife Solutions in a research note issued on Wednesday, January 8th. Northland Capmk analyst C. Byrnes anticipates that the medical equipment
Northland Securities Remains a Buy on BioLife Solutions (BLFS)
BioLife Solutions price target raised to $31 from $28 at Northland
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 404 Shares
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 404 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $27.02, for a total value of $10,916.08. Following the transaction, the executive vice president now directly owns 262,715 shares of the company's stock, valued at approximately $7,098,559.30. The trade was a 0.15 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $26,668.74 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 987 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $27.02, for a total value of $26,668.74. Following the completion of the sale, the chief financial officer now directly owns 121,779 shares in the company, valued at approximately $3,290,468.58. The trade was a 0.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) CEO Greef Roderick De Sells 46,896 Shares
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CEO Greef Roderick De sold 46,896 shares of the firm's stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $23.43, for a total value of $1,098,773.28. Following the completion of the sale, the chief executive officer now owns 414,958 shares in the company, valued at approximately $9,722,465.94. This represents a 10.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Price Target Raised to $31.00 at Northland Securities
Northland Securities lifted their target price on BioLife Solutions from $28.00 to $31.00 and gave the company an "outperform" rating in a research note on Wednesday.
KeyBanc Sticks to Its Buy Rating for BioLife Solutions (BLFS)
BioLife Solutions (BLFS) Receives a Buy from TD Cowen
BioLife Solutions: Optimizing Its Business Model
BioLife Solutions, Inc. stock logo
Jane Street Group LLC Trims Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Jane Street Group LLC lessened its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 47.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 46,654 shares of the medical equipment provider's stock after selling
TD Cowen Remains a Buy on BioLife Solutions (BLFS)
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Recommendation of "Buy" by Brokerages
Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1 year price o
BioLife Solutions, Inc. stock logo
State Street Corp Acquires 95,788 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
State Street Corp lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 7.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,412,316 shares of the medical equipment pr
Benchmark Co. Sticks to Their Buy Rating for BioLife Solutions (BLFS)
BioLife Solutions, Inc. stock logo
BioLife Solutions (NASDAQ:BLFS) Shares Up 4.2% - What's Next?
BioLife Solutions (NASDAQ:BLFS) Shares Up 4.2% - Here's Why
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 7,604 Shares
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 7,604 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $27.33, for a total value of $207,817.32. Following the completion of the sale, the executive vice president now directly owns 276,315 shares in the company, valued at approximately $7,551,688.95. This represents a 2.68 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
BioLife Solutions, Inc. stock logo
BioLife Solutions' (BLFS) "Buy" Rating Reiterated at Benchmark
Benchmark restated a "buy" rating and issued a $30.00 price target on shares of BioLife Solutions in a research report on Thursday.
BioLife Solutions price target raised to $33 from $30 at KeyBanc
BioLife Solutions (BLFS) Receives a Buy from KeyBanc
BioLife Solutions, Inc. stock logo
KeyCorp Forecasts Strong Price Appreciation for BioLife Solutions (NASDAQ:BLFS) Stock
KeyCorp boosted their price objective on shares of BioLife Solutions from $30.00 to $33.00 and gave the company an "overweight" rating in a research note on Friday.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Meros Investment Management LP
Meros Investment Management LP cut its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 56.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 173,910 shares of the medical equipment provider's
BioLife Solutions, Inc. stock logo
Polar Asset Management Partners Inc. Sells 63,000 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Polar Asset Management Partners Inc. trimmed its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 85.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,638 shares of the medical equipment provider's st
BioLife Solutions, Inc. stock logo
Rockefeller Capital Management L.P. Raises Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)
Rockefeller Capital Management L.P. grew its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 81.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 585,497 shares of the medical equipment provider's stock after buying an additional 262,504 shares
BioLife Solutions, Inc. stock logo
D.A. Davidson & CO. Makes New $1.02 Million Investment in BioLife Solutions, Inc. (NASDAQ:BLFS)
D.A. Davidson & CO. purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 40,660 shares of the medical equipment pro
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Update
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 2,680,000 shares, a decrease of 23.4% from the October 31st total of 3,500,000 shares. Based on an average trading volume of 384,000 shares, the short-interest ratio is currently 7.0 days.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells $14,225.60 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 523 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $27.20, for a total transaction of $14,225.60. Following the completion of the sale, the executive vice president now owns 283,919 shares in the company, valued at approximately $7,722,596.80. This trade represents a 0.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $15,803.20 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 581 shares of BioLife Solutions stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $27.20, for a total transaction of $15,803.20. Following the completion of the sale, the chief financial officer now owns 122,766 shares in the company, valued at approximately $3,339,235.20. This represents a 0.47 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
BioLife Solutions, Inc. stock logo
Isthmus Partners LLC Has $3.31 Million Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Isthmus Partners LLC lowered its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 20.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,047 shares of the medical equipment prov
BioLife Solutions, Inc. stock logo
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of "Buy" by Analysts
Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objec
BioLife Solutions, Inc. stock logo
Victory Capital Management Inc. Sells 42,851 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS)
Victory Capital Management Inc. reduced its stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 50.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,934 shares of the medical equipment provide
BioLife Solutions, Inc. stock logo
Research Analysts Issue Forecasts for BLFS Q1 Earnings
BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for BioLife Solutions in a report released on Monday, November 18th. HC Wainwright analyst Y. Chen expects that the medical equipment provider will post
Analyst Expectations For BioLife Solns's Future
BioLife Solutions price target lowered to $27 from $29 at H.C. Wainwright
Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

BLFS Media Mentions By Week

BLFS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLFS
News Sentiment

0.18

0.48

Average
Medical
News Sentiment

BLFS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLFS Articles
This Week

6

4

BLFS Articles
Average Week

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners